WASHINGTON — The neutralizing activity of two doses of Moderna’s COVID-19 vaccine is “substantially low” against the Omicron variant of the coronavirus, National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony Fauci said on Wednesday, citing NIAID data. Read More